is glp 1 safe for kidneys GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease RACGP - GLP-1 receptor agonists

Hulst AH, Polderman JAW, Siegelaar SE, van Raalte DH, DeVries JH, Preckel B, Hermanides J

The advantage is that it acts on the nerves GLP1 drug may have certain effects on the nervous system, mainly manifested as symptoms such as headache and dizziness

Second, the appetite-suppressing effects kick in during the day when you need them most for managing food choices

Emerging research suggests these drugs may reduce inflammation through multiple mechanisms, potentially contributing to their cardiovascular and renal benefits

Provides injectable and oral plan categories

Long-term users of retatrutide who also exercise regularly and have lost significant weight may find their resting heart rate actually lower than pre-treatment levels, because the cardiovascular benefits of weight loss and improved fitness outweigh the modest pharmacological heart rate increase